We are evaluating a new medication for people with advanced cutaneous squamous cell carcinoma to see how safe it is and if it may help improve their condition.
Health conditions and diseases that the clinical trial is designed to study and treat.
Recurrent and metastatic skin squamous cell carcinoma (cSCC) is a type of skin cancer that has returned after treatment or spread to other parts of the body. It often arises from sun-damaged skin and can be challenging to treat, especially in patients who have not received immunotherapy.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
